Aperbio leverages two core technology platforms—nucleic acid molecular detection (dPCR & qPCR) and protein chemiluminescence imaging—to deliver efficient and precise testing solutions for medical research and clinical diagnostics. By integrating these advanced technologies, Aperbio aims to enhance the accuracy, efficiency, and accessibility of disease diagnosis and treatment.

qMate Mini Nucleic Acid Extraction System



